Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_3
1
14%
Ph phase_2
4
57%
Ph phase_4
2
29%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Terminated(1)
Other(6)

Detailed Status

unknown6
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 24 (57.1%)
Phase 31 (14.3%)
Phase 42 (28.6%)

Trials by Status

withdrawn114%
unknown686%

Recent Activity

0 active trials
Showing 5 of 7
unknownphase_2

Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma

NCT03668730
unknownphase_4

Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)

NCT02996214
unknownphase_2

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

NCT03603756
unknownphase_4

Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients

NCT04217096
unknownphase_2

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

NCT03020329
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03668730Phase 2

Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma

Unknown
NCT02996214Phase 4

Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)

Unknown
NCT03603756Phase 2

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

Unknown
NCT04217096Phase 4

Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients

Unknown
NCT03020329Phase 2

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Unknown
NCT01998347Phase 3

Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

Withdrawn
NCT02163291Phase 2

Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7